625470-29-3

Basic information

• Product Name: (3-MORPHOLINOPHENYL)METHYLAMINE
• Synonyms: 1-(3-MORPHOLIN-4-YLPHENYL)METHYLAMINE;3-MORPHOLIN-4-YL-BENZYLAMINE;3-MORPHOLINOBENZYLAMINE;(3-MORPHOLINOPHENYL)METHYLAMINE;(3-Morpholinophenyl)MethanaMine;[3-(Morpholin-4-yl)phenyl]methylamine;3-(Morpholin-4-yl)benzylamine, 4-[3-(Aminomethyl)phenyl]morpholine;[3-(Morpholin-4-yl)phenyl]MethanaMine
• CAS NO: 625470-29-3
• Molecular Formula: C₁₁H₁₆N₂O
• Molecular Weight: 192.26
• Mol File: 625470-29-3.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 362.4 °C at 760 mmHg
• Flash Point: 173 °C
• Appearance: /
• Density: 1.113 g/cm³
• Vapor Pressure: 1.93E-05mmHg at 25°C
• Refractive Index: 1.568
• Storage Temp.: 2-8°C
• PKA: 9.35±0.10(Predicted)
• CAS DataBase Reference: (3-MORPHOLINOPHENYL)METHYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: (3-MORPHOLINOPHENYL)METHYLAMINE(625470-29-3)
• EPA Substance Registry System: (3-MORPHOLINOPHENYL)METHYLAMINE(625470-29-3)

Safety Data

• Hazard Codes: C
• Hazardous Substances Data: 625470-29-3(Hazardous Substances Data)

Usage

General Description

(3-Morpholinophenyl)methylamine is an organic compound with the molecular formula C10H15N. It is a primary amine and consists of a morpholine ring attached to a phenyl ring, with a methylamine group attached to the phenyl ring. This chemical is commonly used in the synthesis of pharmaceuticals and agrochemicals. It may also be used as an intermediate in the production of dyes and pigments. Additionally, it has potential applications in the development of other organic compounds, such as surfactants and lubricants. Overall, (3-Morpholinophenyl)methylamine has a range of industrial uses and is an important building block in organic chemistry.

InChI:InChI=1/C11H16N2O/c12-9-10-2-1-3-11(8-10)13-4-6-14-7-5-13/h1-3,8H,4-7,9,12H2

Downstream Products

• 1160360-48-4 5-((bicyclo[2.2.1]heptan-2-ylmethyl)(3-morpholinobenzyl)amino)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one 
• 1160360-49-5 1-methyl-5-((3-morpholinobenzyl)(2-(tetrahydro-2H-pyran-4-yl)ethyl)amino)-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one 
• 1160360-66-6 3-tert-butyl-5-((cyclohexylmethyl)(3-morpholinobenzyl)amino)-1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one 
• 1160360-77-9 3-tert-butyl-5-((cyclohexylmethyl)(3-morpholinobenzyl)amino)-1-ethyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one 
• 1033443-74-1 3-tert-butyl-5-((3,3-dimethylbutyl)(3-morpholinobenzyl)amino)-1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one 
• 1033443-94-5 3-tert-butyl-1-ethyl-5-(isobutyl(3-morpholinobenzyl)amino)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one 
• 1347756-86-8 (S)-N-(3-(4-morpholinyl)benzyl)-1-(2-((3,4,5-trimethoxyphenyl)amino)-4-pyrimidinyl)-3-piperidinecarboxamide 
• 1033444-18-6 C₁₅H₂₄N₂O 
• 1033444-16-4 C₁₇H₂₈N₂O 
• 1028337-04-3 4-chloro-6-(3-morpholin-4-yl-benzylamino)-2H-phthalazin-1-one 

Relevant articles and documents

SUBSTITUTED 2- AMIDOQUINAZOL-4-ONES AS MATRIX METALLOPROTEINASE-13 INHIBITORS

The present invention provides a novel amide derivative having a matrix metalloproteinase inhibitory activity, and useful as a pharmaceutical agent, which is a compound represented by the formula (I) wherein ring A is an optionally substituted, nitrogen containing heterocycle, ring B is an optionally substituted monocyclic homocycle or an optionally substituted monocyclic heterocycle, Z is N or NR1 (R1 is a hydrogen atom or an optionally substituted hydrocarbon group), is a single bond or a double bond, R2 is a hydrogen atom or an optionally substituted hydrocarbon group, X is an optionally substituted spacer having 1 to 6 atoms, ring C is (1) an optionally substituted homocycle or (2) an optionally substituted heterocycle other than a ring represented by (II) (X′ is S, O, SO, or CH2), and at least one of ring B and ring C has substituent(s), provided that N-{(1S,2R)-1-(3,5-difluorobenzyl)-3-[(3-ethylbenzyl)amino]2 hydroxypropyl}5,6 dimethyl 4 oxo 1,4 dihydrothieno[2,3-d]pyrimidine-2-carboxamide is excluded, or a salt thereof.